Date: Monday, October 15, 2018
Venue: Stanford Faculty Club, Stanford University, 439 Lagunita Drive, Stanford, CA 94305
Event Website: https://vlab.org/events/impact-of-tech-on-Clinical-trials/
Saama will be attending VLAB’s panel discussion on Impact of Technology on Clinical Trials at Stanford University. The panel, moderated by Daniel Kraft, Founder and Chairman, Exponential Medicine, will feature industry experts Wout Brusselaers, Co-Founder and CEO, Deep 6 AI, Dr. Michelle Longmire, Co-Founder and CEO, Medable, Mohanad Fors, Global Head of BIOME – Digital Innovation Lab, Novartis Pharmaceuticals, and Ruchita Sinha, Senior Director of Investments, Sanofi Ventures.
They’ll discuss the possibilities of AI, Mobile, and other emerging tech transforming clinical trials for good. The panel will attempt to find answers for:
- Can these technologies find the right participants for clinical trials?
- Will these new innovations reverse the trend of rising health costs?
- How can AI provide a “shot in the arm” for the clinical trial industry?
Join us for this insightful event by registering here.
The post The Impact of Technology on Clinical Trials – October 15 appeared first on Saama.
